United Therapeutics Corp
XBER:UTH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
United Therapeutics Corp
XBER:UTH
|
US |
|
B
|
BHP Group Ltd
DUS:BHP
|
AU |
|
I
|
Infineon Technologies AG
XMUN:IFX
|
DE |
|
O
|
One Enterprise PCL
SET:ONEE
|
TH |
|
D
|
DSM-Firmenich AG
OTC:DSMFF
|
CH |
|
T
|
TC Energy Corp
XMUN:TRS
|
CA |
|
M
|
Mitsubishi Chemical Holdings Corp
OTC:MTLHY
|
JP |
|
P
|
Pacira Biosciences Inc
F:82P
|
US |
|
C
|
CDW Corp
DUS:CDW
|
US |
|
A
|
Ajinomoto Co Inc
XMUN:AJI
|
JP |
|
X
|
Xtb SA
WSE:XTB
|
PL |
|
Fuji Electric Co Ltd
F:FJE
|
JP |
|
E
|
Estee Lauder Companies Inc
DUS:ELAA
|
US |
|
Ceconomy AG
F:MEOD
|
DE |
|
C
|
Callaway Golf Co
F:CLY
|
US |
|
S
|
SMCP SA
SWB:SFC
|
FR |
|
I
|
Interpublic Group of Companies Inc
F:IPG
|
US |
|
A
|
AXA SA
MIL:AXA
|
FR |
|
D
|
DR Horton Inc
DUS:HO2
|
US |
|
T
|
Talanx AG
DUS:TLX
|
DE |
|
W
|
W5 Solutions AB (publ)
STO:W5
|
SE |
|
Guardant Health Inc
NASDAQ:GH
|
US |
Wall St Price Targets
UTH Price Targets Summary
United Therapeutics Corp
According to Wall Street analysts, the average 1-year price target for UTH is 577.71 EUR with a low forecast of 451.59 EUR and a high forecast of 660.91 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is UTH's stock price target?
Price Target
577.71
EUR
According to Wall Street analysts, the average 1-year price target for UTH is 577.71 EUR with a low forecast of 451.59 EUR and a high forecast of 660.91 EUR.
What is the Revenue forecast for United Therapeutics Corp?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 8 years is 13%.
What is the Gross Profit forecast for United Therapeutics Corp?
Projected CAGR
15%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 6 years is 15%.
What is the Operating Income forecast for United Therapeutics Corp?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 8 years is 14%.
What is the Pre-Tax Income forecast for United Therapeutics Corp?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 10%.
What is the Net Income forecast for United Therapeutics Corp?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 8 years is 11%.
